PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)

被引：0
|
作者：
Cereda, S. [1 ]
Mazza, E. [1 ]
Vitali, G. [1 ]
Passoni, P. [1 ]
Balzano, G. [1 ]
Zerbi, A. [1 ]
Staudacher, C. [1 ]
Di Carlo, V [1 ]
Reni, M. [1 ]
机构：
[1] S Raffaele Sci Inst, Dept Oncol Radiotherapy & Surg, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI50 / XI50
页数：1
相关论文
共 50 条
  • [1] PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Passoni, P.
    Nicoletti, R.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    di Carlo, V
    Reni, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 58 - 59
  • [2] Weekly Epirubicin as Salvage Therapy in Patients with Gemcitabine-Resistant Advanced Pancreatic Cancer
    Cereda, S.
    Rognone, A.
    Mazza, E.
    Fugazza, C.
    Ceraulo, D.
    Villa, E.
    Reni, M.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 698 - 700
  • [3] SALVAGE THERAPY WITH MITOMYCIN AND IFOSFAMIDE (MI) IN PATIENTS WITH GEMCITABINE-RESISTANT METASTATIC PANCREATIC CANCER
    Cereda, S.
    Ghidini, M.
    Passoni, P.
    Rognone, A.
    Fugazza, C.
    Ceraulo, D.
    Mazza, E.
    Nicoletti, R.
    Villa, E.
    Reni, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 186
  • [4] Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial
    Cereda, Stefano
    Reni, Michele
    Rognone, Alessia
    Fugazza, Clara
    Ghidini, Michele
    Ceraulo, Domenica
    Brioschi, Matteo
    Nicoletti, Roberto
    Villa, Eugenio
    CHEMOTHERAPY, 2011, 57 (02) : 156 - 161
  • [5] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 113 - 123
  • [6] Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    M Reni
    L Pasetto
    G Aprile
    S Cordio
    E Bonetto
    S Dell'oro
    P Passoni
    L Piemonti
    C Fugazza
    G Luppi
    C Milandri
    R Nicoletti
    A Zerbi
    G Balzano
    V Di Carlo
    A A Brandes
    British Journal of Cancer, 2006, 94 : 785 - 791
  • [7] Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    Reni, M
    Pasetto, L
    Aprile, G
    Cordio, S
    Bonetto, E
    Dell'Oro, S
    Passoni, P
    Piemonti, L
    Fugazza, C
    Luppi, G
    Milandri, C
    Nicoletti, R
    Zerbi, A
    Balzano, G
    Di Carlo, V
    Brandes, AA
    BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 785 - 791
  • [8] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (03): : 288 - 289
  • [9] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Kentaro Sudo
    Taketo Yamaguchi
    Kazuyoshi Nakamura
    Tadamichi Denda
    Taro Hara
    Takeshi Ishihara
    Osamu Yokosuka
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 249 - 254
  • [10] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Sudo, Kentaro
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Denda, Tadamichi
    Hara, Taro
    Ishihara, Takeshi
    Yokosuka, Osamu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 249 - 254
12345